BAUSCH + LOMB CORP (BLCO:NYSE)
$18.43 0.55 (3.0761%)
Analysed BAUSCH + LOMB CORP (BLCO:NYSE) News Sources
Bausch + Lomb Announces New Published Research on enVista Aspire™ Real World Experience
02-09-2026
yahoo.com
Insider Sheds Nearly 53,000 Shares of Consumer Health Stock, Valued at Almost $900,000
13-08-2026
fool.com
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
24-08-2026
yahoo.com
Bausch + Lomb Plans to Advance Dual-Action Eye Drop Targeting Evaporative and Inflammatory Dry Eye Disease to Phase 3
24-08-2026
yahoo.com
Bausch + Lomb Advances Dry Eye Drug to Phase III as Pain Candidate Hits Phase Ib Goal
25-08-2026
marketbeat.com
Bausch + Lomb Advances Two First-in-Class Eye Health Therapies
25-08-2026
yahoo.com
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q2 Earnings: Bausch + Lomb (NYSE:BLCO) Vs The Rest Of The Pack
25-08-2026
yahoo.com
3 Healthcare Stocks We Steer Clear Of
27-08-2026
yahoo.com
Bausch + Lomb (BLCO) Stock Trades Below Fair Value As Caution Lingers
29-08-2026
yahoo.com
Most Women Don't Recognize Dry Eye as a Symptom of Perimenopause and Menopause, New Bausch + Lomb Survey Finds
01-09-2026
yahoo.com
What is the current price of BAUSCH + LOMB CORP (BLCO:NYSE)?
The current price of BAUSCH + LOMB CORP (BLCO:NYSE) is $18.43.
BAUSCH + LOMB CORP (BLCO:NYSE) absolute price change since previous trading day?
The absolute price change of BAUSCH + LOMB CORP (BLCO:NYSE) since the previous trading day is $0.55.
BAUSCH + LOMB CORP (BLCO:NYSE) percentage price change since previous trading day?
The percentage price change of BAUSCH + LOMB CORP (BLCO:NYSE) since the previous trading day is 3.0761%.
What is the most recent average sentiment score for BAUSCH + LOMB CORP (BLCO:NYSE)?
The most recent average sentiment score for BAUSCH + LOMB CORP (BLCO:NYSE) is 63 out of 100.
What is the most recent average sentiment for BAUSCH + LOMB CORP (BLCO:NYSE)?
The most recent sentiment for BAUSCH + LOMB CORP (BLCO:NYSE) is .
SEC-8K** Filing Available For BAUSCH + LOMB CORP (BLCO:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.